Cargando…
Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis
BACKGROUND: It is unclear whether S-1 plus cisplatin is effective for patients with recurrent gastric cancer after adjuvant S-1 chemotherapy. METHODS: We retrospectively evaluated the efficacy of S-1 plus cisplatin in patients whose gastric cancer recurred after adjuvant S-1 chemotherapy. RESULTS: I...
Autores principales: | Shitara, Kohei, Morita, Satoshi, Fujitani, Kazumasa, Kadowaki, Shigenori, Takiguchi, Nobuhiro, Hirabayashi, Naoki, Takahashi, Masazumi, Takagi, Masakazu, Tokunaga, Yukihiko, Fukushima, Ryoji, Munakata, Yasuhiro, Nishikawa, Kazuhiro, Takagane, Akinori, Tanaka, Takaho, Sekishita, Yoshiaki, Sakamoto, Junichi, Tsuburaya, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390702/ https://www.ncbi.nlm.nih.gov/pubmed/21993850 http://dx.doi.org/10.1007/s10120-011-0101-x |
Ejemplares similares
-
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
por: Aoyama, Toru, et al.
Publicado: (2014) -
The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2018) -
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
por: Shitara, Kohei, et al.
Publicado: (2019) -
Recurring radiation-induced angiosarcoma of the breast that was treated with paclitaxel chemotherapy: a case report
por: Suzuki, Yoko, et al.
Publicado: (2020) -
Chemotherapy-Induced Sclerosing Cholangitis Caused by Systemic Chemotherapy
por: Kusakabe, Akira, et al.
Publicado: (2019)